The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article | The Journal of Antibiotics:
https://www.nature.com/articles/s41429-021-00430-5
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577703/
A review of the anti-viral effects of ivermectin | African Journal of Clinical and Experimental Microbiology:
https://www.ajol.info/index.php/ajcem/article/view/209853
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen | The Journal of Antibiotics
https://www.nature.com/articles/s41429-020-0336-z
Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment – Li – 2021 – Journal of Cellular Physiology – Wiley Online Library:
https://onlinelibrary.wiley.com/doi/10.1002/jcp.30055
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652439/
And the rest of the other Ivermectin studies and meta-analysis: